Skip to content
Home/Companies/Software/RebrAIn
RebrAIn

RebrAIn

Software·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns RebrAIn?

RebrAIn is currently owned by Karista through Karista HealthTech Fund (2021 vintage), since 2023.

Hand-verified · updated 2026-04-21

Karista
Investor
Karista
Karista HealthTech Fund · 2021 · VC

Key facts

HQFrance
SectorSoftware
Websiterebrain.eu

More from Karista HealthTech Fund

Other portfolio companies in the same fund.

Waiv
Waiv
Active
HealthcareFrance· 2026
SamanTree Medical
SamanTree Medical
Active
HealthcareSwitzerland· 2025
Deemea
Active
HealthcareFrance· 2024
Kranus Health
Kranus Health
Active
HealthTechGermany· 2022
Ludocare
Ludocare
Active
HealthTechFrance· 2022
Brightflow
Brightflow
Active
HealthcareFrance· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track RebrAIn

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy RebrAIn?

1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on RebrAIn.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue